Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection

  • Guo TANG ,
  • Li LONG ,
  • Ya-xin HAN ,
  • Qing PENG ,
  • Jia-jun LIU ,
  • Hua SHANG
Expand
  • 1. Department of Rheumatology and Immunology, The Bishan Hospital of Chongqing, Chongqing 402760, China
    2. Department of Rheumatology and Immunology, Sichuan Provincial People’s Hospital, Chengdu 610000, China
    3. Department of Rheumatology and Immunology, The People’s Hospital of Wenjiang, Chendu 610000, China
    4. The First Clinical Institute, Zunyi Medical University, Zunyi 563000, Guizhou, China

Received date: 2020-07-30

  Online published: 2020-12-13

Abstract

Objective: To investigate the clinical characteristics and high risk factors of Rheumatoid arthritis (RA) complicated with tuberculosis infection. Methods: Patients with rheumatoid arthritis diagnosed in the hospital of Sichuan Provincial People’s Hospital from January 2007 to January 2017 was retrospectively collected, who were enrolled in the study group. A control group was randomly selected from the RA patients hospitalized in the same period without co-infection at a ratio of 1:2. The general data, clinical data, laboratory test data, treatment plan, etc. of the two groups were collected in detail for single factor statistical analysis. Then multivariate Logistic regression was used to analyze the independent risk factors of RA complicated with tuberculosis infection with statistical significance in univariate analysis. Results: The clinical manifestations of fever (83.3%) were most common, followed by cough (69%) and body mass loss (45.2%). In the infected group, pulmonary tuberculosis accounted for 73.3%. In the infected group the chest CT showed two or more cases, accounting for 59%. There were 9 cases (33.3%) occurring in the typical tuberculosis occurrence site. Compared with the control group, the erythrocyte sedimentation rate (ESR), C-reaction protein (CRP) levels, and the daily average dose of glucocorticoid in 1 year in the infected group were higher than those in the control group. And those differences were statistically significant(P<0.05). There were no significant differences in gender, age, disease duration, disease activity score, white blood cell (WBC), platelet (PLT), hemoglobin (Hb), immunoglobulin G (IgG), complement (C), Anti cyclic citrullinated peptide antibody (anti-CCP), CD4+T cell count, and immunosuppressant use (P>0.05). Multivariate Logistic regression analysis showed that CRP levels(OR=1.016, 95%CI:1.002-1.031) and the daily average dose of glucocorticoid in 1 year(OR=1.229, 95%CI:1.066-1.418)were the independent risk factors of RA complica-ted with tuberculosis infection. Conclusion: RA patients with tuberculosis infection are mainly phthisis. The clinical manifestations of RA combined with tuberculosis infection are lack of specificity, and the chest imaging features of pulmonary tuberculosis are diverse, which are easy to be misdiagnosed. CRP levels and the daily average dose level of glucocorticoid in 1 year were risk factors for RA and tuberculosis infection.

Cite this article

Guo TANG , Li LONG , Ya-xin HAN , Qing PENG , Jia-jun LIU , Hua SHANG . Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection[J]. Journal of Peking University(Health Sciences), 2020 , 52(6) : 1029 -1033 . DOI: 10.19723/j.issn.1671-167X.2020.06.007

References

[1] Justin L, Warren F, Wijaya L, et al. Disseminated tuberculosis masquerading as a presentation of systemic lupus erythematosus[J]. Int J Rheum Dis, 2018,21(1):352-355.
[2] World Health Organization. Global Tuberculosis Report 2019[EB/OL].(2019-12-12)[2020-04-10]. https://www.who.int/tb/publications/global_report/en.
[3] 刘二勇, 周林, 成诗明. 结核分枝杆菌潜伏性感染及预防性治疗研究进展的系统评价[J]. 中国防痨杂志, 2013,35(4):231-239.
[4] Chung T, Ko H, Lau C, et al. A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis[J]. Rheumatol Int, 2020,40(6):983-990.
[5] Christy H, Mike O, Jessie B, et al. Finding the missing patients with tuberculosis: lessons learned from patient-pathway analyses in 5 countries[J]. J Infect Dis, 2017,216(7):686-695.
[6] Handa R, Upadhyaya S, Kapoor S, et al. Tuberculosis and biologics in rheumatology: A special situation[J]. Int J Rheum Dis, 2017,51(10):115.
[7] Chin DP, Hanson C L. Finding the missing tuberculosis patients[J]. J Infect Dis, 2017,216(7):675-678.
[8] Balsa A, Carmona L, González-Alvaro I, et al. Value of disease activity score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.[J]. J Rheumatol, 2004,31(1):40.
[9] 中华人民共和国国家卫生健康委员会. 结核病分类(WS196—2017)[J]. 新发传染病电子杂志, 2018,3(3):191-192.
[10] 中华人民共和国国家卫生健康委员会. 肺结核诊断标准(WS 288—2017)[J]. 新发传染病电子杂志, 2018,3(1):59-61.
[11] Franco MD, Lucchino B, Spaziant M, et al. Lung infections in systemic rheumatic disease: focus on opportunistic infections.[J]. Int J Mol Sci, 2017,18(2):293.
[12] Ni Mhuircheartaigh OM, Matteson EL, Green AB, et al. Trends in serious infections in rheumatoid arthritis[J]. J Rheumatol, 2013,40(5):611-616.
[13] Anton C, Machado FD, Ramirez JMA, et al. Latent tuberculosis infection in patients with rheumatic diseases[J]. J Bras Pneumol, 2019,45(2):e20190023.
[14] 邓国防, 王玉香, 陈涛, 等. 风湿免疫性疾病并发结核感染的临床特征分析[J]. 中国防痨杂志, 2018,40(4):392-396.
[15] Hong LC, Hsin-Hua C, Yi-Hsing C, et al. The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.[J]. PLoS One, 2017,12(6):e0178035.
[16] Youssef J, Novosad SA, Winthrop KL, et al. Infection risk and safety of corticosteroid use[J]. Clin Rheum Dis, 2016,42(1):157-176.
Outlines

/